ARCHIVES

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 21 No. 33 | August 18, 1995

Download PDF Visit The Full Archive

Related Articles

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

Panel Resumes Deliberations

January 4, 1980

In Brief: Three NCI Basic Science Centers Rank In Index Of Citations; Novello: Help More Smokers Quit

August 2, 1991

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009